{"altmetric_id":13589152,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":15},"twitter":{"unique_users_count":11,"unique_users":["PLMcCarthyMD","CGiampalmi","FrancescoTurtu1","haematologica","UofH_Blood","queizan","DanielleHammo20","hematoonkologia","jose6xxx","SCTNB","HematologiaMex"],"posts_count":13},"facebook":{"unique_users_count":2,"unique_users":["481793341830737","390538804466274"],"posts_count":2}},"selected_quotes":["Evaluation of the new R-ISS for Multiple Myeloma risk stratification in 475 unselected patients","Evaluation of the Revised International Staging System in an independent cohort of unselected patients with Myeloma","Evaluation of the Revised ISSin an independent cohort of unselected patients with #multiplemyeloma","Evaluation of Revised International Staging Sys (R-ISS) in ind cohort of unselected pts w multiple #myeloma PubMed","Revised International Staging System (R-ISS) in an independent cohort of unselected patients with multiple myeloma"],"citation":{"abstract":"The revised International Staging System (R-ISS) was recently introduced in order to improve risk stratification over the widely used ISS. R-ISS incorporates, in addition to ISS, the presence of chromosomal abnormalities detected by iFISH (t(4;14), t(14;16) and del17p) and elevated serum lactate dehydrogenase. R-ISS formulation was based on a large dataset of selected patients who had participated in clinical trials and has not been validated in an independent cohort of unselected patients. Thus, we evaluated R-ISS in 475 consecutive, unselected patients, treated in a single center. Our patients were older and had more often severe renal dysfunction than those of the original publication of R-ISS. Per R-ISS, 18% had R-ISS-1, 64.5% R-ISS-2 and 17.5% R-ISS-3. According to R-ISS, the 5-year survival rate was 77%, 53% and 19% for R-ISS-1, -2 and -3, respectively (p<0.001). R-ISS could identify three groups with distinct outcomes among patients treated with or without autologous stem cell transplantation, among those treated with either bortezomib-based or IMiD-based primary therapy and in patients \u226465, 66-75 or >75 years. However, in patients with severe renal dysfunction the distinction between groups was less clear. In conclusion, our data in consecutive, unselected patients, with differences in the characteristics and treatment approaches compared to the original International Myeloma Working Group (IMWG) cohort, verified that R-ISS is a robust tool for risk stratification of newly diagnosed patients with symptomatic myeloma.","altmetric_jid":"4f6fa61a3cf058f6100075cb","authors":["Efstathios Kastritis","Evangelos Terpos","Maria Roussou","Maria Gavriatopoulou","Magdalini Migkou","Evangelos Eleutherakis-Papaiakovou","Despoina Fotiou","Dimitrios Ziogas","Ioannis Panagiotidis","Eftychia Kafantari","Stavroula Giannouli","Athanasios Zomas","Konstantinos Konstantopoulos","Meletios A. Dimopoulos","Kastritis, Efstathios","Terpos, Evangelos","Roussou, Maria","Gavriatopoulou, Maria","Migkou, Magdalini","Eleutherakis-Papaiakovou, Evangelos","Fotiou, Despoina","Ziogas, Dimitrios","Panagiotidis, Ioannis","Kafantari, Eftychia","Giannouli, Stavroula","Zomas, Athanasios","Konstantopoulos, Konstantinos","Dimopoulos, Meletios A"],"doi":"10.3324\/haematol.2016.145078","first_seen_on":"2016-11-14T12:19:58+00:00","funders":["niehs"],"issns":["1592-8721","0390-6078"],"journal":"Haematologica","last_mentioned_on":1492101820,"links":["http:\/\/www.haematologica.org\/content\/early\/2016\/10\/21\/haematol.2016.145078","https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/27789676\/?i=3&from=Kastritis%20E%5Bau%5D","http:\/\/www.haematologica.org\/content\/102\/3\/593?etoc=","http:\/\/www.haematologica.org\/content\/102\/3\/593?utm_content=buffer19cd9&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer","http:\/\/www.haematologica.org\/content\/102\/3\/593?utm_content=bufferefb01&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer","http:\/\/www.haematologica.org\/content\/102\/3\/593"],"pdf_url":"http:\/\/haematologica.org\/content\/haematol\/early\/2016\/10\/21\/haematol.2016.145078.full.pdf","pmid":"27789676","pubdate":"2016-10-27T00:00:00+00:00","publisher":"Haematologica","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["hematology"],"title":"Evaluation of the Revised International Staging System (R-ISS) in an independent cohort of unselected patients with multiple myeloma","type":"article","uri":"http:\/\/www.haematologica.org\/lookup\/doi\/10.3324\/haematol.2016.145078","mendeley_url":"http:\/\/www.mendeley.com\/research\/evaluation-revised-international-staging-system-independent-cohort-unselected-patients-multiple-myel"},"altmetric_score":{"score":7.5,"score_history":{"1y":7.5,"6m":6.75,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.5},"context_for_score":{"all":{"total_number_of_other_articles":8069307,"mean":6.8479199559378,"rank":1103536,"this_scored_higher_than_pct":86,"this_scored_higher_than":6959778,"rank_type":"exact","sample_size":8069307,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":233020,"mean":13.0964865011,"rank":48486,"this_scored_higher_than_pct":79,"this_scored_higher_than":184355,"rank_type":"exact","sample_size":233020,"percentile":79},"this_journal":{"total_number_of_other_articles":1155,"mean":4.9146672443674,"rank":82,"this_scored_higher_than_pct":92,"this_scored_higher_than":1073,"rank_type":"exact","sample_size":1155,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":49,"mean":7.259375,"rank":10,"this_scored_higher_than_pct":79,"this_scored_higher_than":39,"rank_type":"exact","sample_size":49,"percentile":79}}},"demographics":{"poster_types":{"member_of_the_public":9,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":9,"Science communicators (journalists, bloggers, editors)":1,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Unspecified":1,"Researcher":2,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Other":1,"Student  > Master":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":8,"Social Sciences":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"US":2,"IT":1,"GB":1,"CA":2,"PL":1,"ES":1,"MX":1},"mendeley":{"DK":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/PLMcCarthyMD\/statuses\/798138347608801280","license":"gnip","citation_ids":[13589152],"posted_on":"2016-11-14T12:19:45+00:00","author":{"name":"Philip McCarthy","image":"https:\/\/pbs.twimg.com\/profile_images\/466351626219823104\/K2IQ5P6I_normal.jpeg","description":"Interested in hematopoietic cell transplantation and hematologic disorders with emphasis on multiple myeloma, AML, ALL, MDS, NHL, HL, CLL, CML","id_on_source":"PLMcCarthyMD","tweeter_id":"454898193","geo":{"lt":42.88645,"ln":-78.87837,"country":"US"},"followers":1941},"tweet_id":"798138347608801280"},{"url":"http:\/\/twitter.com\/CGiampalmi\/statuses\/802875404352684032","license":"gnip","citation_ids":[13589152],"posted_on":"2016-11-27T14:03:07+00:00","author":{"name":"Carole S Giampalmi","image":"https:\/\/pbs.twimg.com\/profile_images\/673310238087520256\/7cmWMq3g_normal.jpg","description":"SMM Mayo, Roch 5\/2005. 2 HPTh surgeries. Related? MM ptrnl grndmthr. Lt chains ratio sporadic (10 to 5). Trisomy 11. Cyclin D1. MDR1 gene. Healed BRONJ. SMM?","id_on_source":"CGiampalmi","tweeter_id":"2953567096","geo":{"lt":null,"ln":null},"followers":163},"tweet_id":"802875404352684032"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/statuses\/837358656370982913","license":"gnip","citation_ids":[13589152],"posted_on":"2017-03-02T17:47:15+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"837358656370982913"},{"url":"http:\/\/twitter.com\/haematologica\/statuses\/841680470698053632","license":"gnip","citation_ids":[13589152],"posted_on":"2017-03-14T16:00:36+00:00","author":{"name":"Haematologica","url":"http:\/\/www.haematologica.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2694311828\/3b3efe7ee65409ca11124d3fb2429e5d_normal.jpeg","description":"Haematologica: the journal of the European Hematology Association (EHA), open access journal","id_on_source":"haematologica","tweeter_id":"583528006","geo":{"lt":45.18446,"ln":9.16145,"country":"IT"},"followers":1893},"tweet_id":"841680470698053632"},{"url":"http:\/\/twitter.com\/haematologica\/statuses\/841680490516094976","license":"gnip","citation_ids":[13589152],"posted_on":"2017-03-14T16:00:41+00:00","author":{"name":"Haematologica","url":"http:\/\/www.haematologica.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2694311828\/3b3efe7ee65409ca11124d3fb2429e5d_normal.jpeg","description":"Haematologica: the journal of the European Hematology Association (EHA), open access journal","id_on_source":"haematologica","tweeter_id":"583528006","geo":{"lt":45.18446,"ln":9.16145,"country":"IT"},"followers":1893},"tweet_id":"841680490516094976"},{"url":"http:\/\/twitter.com\/UofH_Blood\/statuses\/841741625923653632","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-14T20:03:37+00:00","author":{"name":"Sean Frost","image":"https:\/\/pbs.twimg.com\/profile_images\/486489175944728577\/x55oLhLV_normal.jpeg","description":"Haematology nerd\/lecturer @UniofHull, European. Blood Science Rocks. All opinions are my own","id_on_source":"UofH_Blood","tweeter_id":"2611565724","geo":{"lt":53.7446,"ln":-0.33525,"country":"GB"},"followers":170},"tweet_id":"841741625923653632"},{"url":"http:\/\/twitter.com\/UofH_Blood\/statuses\/841741671893209088","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-14T20:03:48+00:00","author":{"name":"Sean Frost","image":"https:\/\/pbs.twimg.com\/profile_images\/486489175944728577\/x55oLhLV_normal.jpeg","description":"Haematology nerd\/lecturer @UniofHull, European. Blood Science Rocks. All opinions are my own","id_on_source":"UofH_Blood","tweeter_id":"2611565724","geo":{"lt":53.7446,"ln":-0.33525,"country":"GB"},"followers":170},"tweet_id":"841741671893209088"},{"url":"http:\/\/twitter.com\/queizan\/statuses\/841746191188688898","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-14T20:21:45+00:00","author":{"name":"Dr. Jos\u00e9 A. Queiz\u00e1n","image":"https:\/\/pbs.twimg.com\/profile_images\/805313113016799232\/jBSTAjA7_normal.jpg","description":"Medico Especialista en Hematologia y Hemoterapia","id_on_source":"queizan","tweeter_id":"2334315479","geo":{"lt":null,"ln":null},"followers":403},"tweet_id":"841746191188688898"},{"url":"http:\/\/twitter.com\/DanielleHammo20\/statuses\/841747544648650752","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-14T20:27:08+00:00","author":{"name":"Danielle Hammond","image":"https:\/\/pbs.twimg.com\/profile_images\/674461112851685382\/RA005WEJ_normal.jpg","description":"AKA Dee. Future hematologist, Kingston native, lover of animals, and a punner seeking forgiveness.","id_on_source":"DanielleHammo20","tweeter_id":"4246291953","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":182},"tweet_id":"841747544648650752"},{"url":"http:\/\/twitter.com\/hematoonkologia\/statuses\/842378405509230592","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-16T14:13:57+00:00","author":{"name":"hematoonkologia.pl","url":"https:\/\/hematoonkologia.pl\/","image":"https:\/\/pbs.twimg.com\/profile_images\/826378934623358976\/MU2nzleC_normal.jpg","description":"hematoonkologia.pl to strona edukacyjna zaadresowana do lekarzy hematolog\u00f3w, lekarzy w trakcie specjalizacji oraz lekarzy pierwszego kontaktu.","id_on_source":"hematoonkologia","tweeter_id":"826052311478915072","geo":{"lt":51,"ln":23,"country":"PL"},"followers":12},"tweet_id":"842378405509230592"},{"url":"http:\/\/twitter.com\/jose6xxx\/statuses\/842769239085928449","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-03-17T16:06:59+00:00","author":{"name":"Jos\u00e9 L. Garc\u00eda","url":"https:\/\/es.linkedin.com\/in\/jose0","image":"https:\/\/pbs.twimg.com\/profile_images\/610876993354264577\/iveN_9iL_normal.jpg","description":"Especialista en Bioqu\u00edmica Cl\u00ednica y An\u00e1lisis Cl\u00ednicos. Complejo Hospitalario Universitario de Granada","id_on_source":"jose6xxx","tweeter_id":"406496525","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":495},"tweet_id":"842769239085928449"},{"url":"http:\/\/twitter.com\/SCTNB\/statuses\/843428508886089728","license":"gnip","citation_ids":[13589152],"posted_on":"2017-03-19T11:46:41+00:00","author":{"name":"Dr T. Comeau , MD","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000365246082\/373bc9bced36e8f90f0d52d727fc6b34_normal.jpeg","description":"Director New Brunswick Stem Cell Transplant Program ; SCT Physician ; #hematology: #leukemia, #MDS, #lymphoma, #mmsm , #apheresis, #bmtsm , #immunotherapy","id_on_source":"SCTNB","tweeter_id":"314498013","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":1150},"tweet_id":"843428508886089728"},{"url":"http:\/\/twitter.com\/HematologiaMex\/statuses\/852562943157960704","license":"gnip","rt":["haematologica"],"citation_ids":[13589152],"posted_on":"2017-04-13T16:43:40+00:00","author":{"name":"Hematolog\u00eda MXQ","url":"https:\/\/plus.google.com\/115132871218033964671","image":"https:\/\/pbs.twimg.com\/profile_images\/847191299715485697\/h_g3Ea8f_normal.jpg","id_on_source":"HematologiaMex","tweeter_id":"750876109466730497","geo":{"lt":19.64388,"ln":-99.21598,"country":"MX"},"followers":15},"tweet_id":"852562943157960704"}],"facebook":[{"title":"Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1518710714805656&id=481793341830737","license":"public","citation_ids":[13589152],"posted_on":"2017-03-14T16:00:32+00:00","summary":"Multiple myeloma is a heterogeneous disease and the development of a risk stratification tool has been challenging. The new R-ISS combines the ISS together with characteristics of the myeloma clone (cytogenetic abnormalities) and elements of the aggressive","author":{"name":"Haematologica","url":"https:\/\/www.facebook.com\/481793341830737","facebook_wall_name":"Haematologica","image":"https:\/\/graph.facebook.com\/481793341830737\/picture","id_on_source":"481793341830737"}},{"title":"Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=670495126470639&id=390538804466274","license":"public","citation_ids":[13589152],"posted_on":"2017-03-22T22:59:50+00:00","summary":"The Revised International Staging System (R-ISS) was recently introduced in order to improve risk stratification over that provided by the widely used standard International Staging System. In addition to the parameters of the standard system, the R-ISS in","author":{"name":"Hematolog\u00eda Mexiquense.            Diagn\u00f3stico cl\u00ednico y tratamiento","url":"https:\/\/www.facebook.com\/390538804466274","facebook_wall_name":"Hematolog\u00eda Mexiquense.            Diagn\u00f3stico cl\u00ednico y tratamiento","image":"https:\/\/graph.facebook.com\/390538804466274\/picture","id_on_source":"390538804466274"}}]}}